The goal of the SECURE-PCI trial was to compare the safety and efficacy of two loading doses of atorvastatin (80 mg) given early among patients presenting with acute coronary syndrome (ACS) for whom an early invasive approach was planned.

Older adults with type 2 diabetes mellitus are a large, heterogeneous and growing population who are at high risk for adverse cardiovascular events.

During the clinician-patient discussion at today's visit, you express concern about the patient's high atherosclerotic cardiovascular disease risk…